Sales - MM+M - Medical Marketing and Media

Sales

All articles by Sales

Syneos study: Hybrid detailing efforts maintain momentum
Syneos study: Hybrid detailing efforts maintain momentum
Lecia Bushak
September 17, 2021
12:07 pm

While face-to-face detailing will never entirely disappear, the digital transformation spurred by COVID-19 has altered the promotional landscape.

Populus expands sales and biz-dev teams
Populus expands sales and biz-dev teams
Larry Dobrow
April 21, 2021
4:01 pm

The company has added execs from the point-of-care and agency worlds.

Purdue’s Point of No Return
Purdue’s Point of No Return
Marc Iskowitz
February 22, 2018
9:00 pm

Purdue’s decision to pull OxyContin sales reps highlights what has been the biggest part of marketing budgets. Did we just see the tipping point?

Five things for pharma marketers to know: Monday, January 22, 2018
Five things for pharma marketers to know: Monday, January 22, 2018
Virginia Lau
January 22, 2018
3:27 pm

Sanofi to buy Bioverativ for $11.6 billion; Celgene to acquire Juno for $9 billion; Teva to lay off more than 200 in Philadelphia

Five things for pharma marketers to know: Wednesday, January 17, 2018
Five things for pharma marketers to know: Wednesday, January 17, 2018
Virginia Lau
January 17, 2018
3:20 pm

Celgene reportedly in talks to buy Juno; Novartis’ Kymriah receives fast-track reviews in U.S. and Europe; BI’s Gilotrif gets expanded approval in lung cancer

Five things for pharma marketers to know: Tuesday, December 26, 2017
Five things for pharma marketers to know: Tuesday, December 26, 2017
Virginia Lau
December 26, 2017
3:25 pm

Roche to buy Ignyta for $1.7 billion; FDA OKs Valeant eye drop for OTC sale; Kmart settles prescription drug fraud allegations

Five things for pharma marketers to know: Wednesday, December 20, 2017
Five things for pharma marketers to know: Wednesday, December 20, 2017
Virginia Lau
December 20, 2017
2:20 pm

Tax bill could lead pharma to move overseas; global pharma sales increased 45% in nine years; FDA OKs first gene therapy for rare retinal disease

Five things for pharma marketers to know: Thursday, December 14, 2017
Five things for pharma marketers to know: Thursday, December 14, 2017
Virginia Lau
December 14, 2017
3:25 pm

Pharma R&D return on investment falls to eight-year low; FDA approves Pfizer’s biosimilar to J&J’s Remicade; Novartis to downsize generics business

Five things for pharma marketers to know: Wednesday, December 13, 2017
Five things for pharma marketers to know: Wednesday, December 13, 2017
Virginia Lau
December 13, 2017
3:35 pm

Teva diminishes debt with job cuts and sale; FDA to study whether consumers can detect misleading ads; AbbVie, Roche present positive Phase-III data at ASH

Five things for pharma marketers to know: Wednesday, November 29, 2017
Five things for pharma marketers to know: Wednesday, November 29, 2017
Virginia Lau
November 29, 2017
3:25 pm

U.K. to be first to sell OTC Viagra; Regeneron offers startup scientific expertise; docs more likely to get poor marks when they reject patient requests

  • Culture drives the company

    Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.

  • From Our Partners